NYSE ARCA | ETF
The fund invests, under normal circumstances, at least 80% of its net assets plus any borrowings for investment purposes (measured at the time of purchase) in equity investments inU. S. and non-U.S. health care companies.
The adviser generally intends to invest in companies that the adviser believes are aligned with key themes associated with innovation in health care, which include, but are not limited to, genomics, precision medicine, technology-enabled procedures, and digital healthcare.
The fund is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| LLY | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 10.30% |
| AZN | AstraZeneca PLC | Healthcare | Drug Manufacturers - General | 6.30% |
| 0QIU | Novo Nordisk A/S Class B | 5.99% | ||
| BSX | Boston Scientific Corp | Healthcare | Medical Devices | 5.84% |
| ISRG | Intuitive Surgical Inc | Healthcare | Medical Instruments & Supplies | 4.92% |
| ABBV | AbbVie Inc | Healthcare | Drug Manufacturers - General | 4.74% |
| AMGN | Amgen Inc | Healthcare | Drug Manufacturers - General | 4.57% |
| DHR | Danaher Corporation | Healthcare | Diagnostics & Research | 3.88% |
| MTD | Mettler-Toledo International Inc | Healthcare | Diagnostics & Research | 3.57% |
| HUM | Humana Inc | Healthcare | Healthcare Plans | 3.48% |
| PODD | Insulet Corporation | Healthcare | Medical Devices | 3.39% |
| COO | The Cooper Companies Inc. | Healthcare | Medical Instruments & Supplies | 3.36% |
| NBIX | Neurocrine Biosciences Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 3.27% |
| ABT | Abbott Laboratories | Healthcare | Medical Devices | 3.15% |
| CSL | CSL Ltd | Healthcare | Biotechnology | 3.06% |
| BMRN | Biomarin Pharmaceutical Inc | Healthcare | Biotechnology | 2.99% |
| BIIB | Biogen Inc | Healthcare | Drug Manufacturers - General | 2.83% |
| LONN | Lonza Group AG | Healthcare | Diagnostics & Research | 2.49% |
| BMY | Bristol-Myers Squibb Company | Healthcare | Drug Manufacturers - General | 2.45% |
| NOVO-B | Novo Nordisk A/S | Healthcare | Biotechnology | 2.34% |